Acalabrutinib is used for adult patients with:
chronic lymphocytic leukemia (CLL)
small lymphocytic lymphoma (SLL)
mantle cell lymphoma (MCL) patients
who have already received at least one other treatment for their cancer.
that is untreated, to be used with bendamustine and rituximab, and they are ineligible for autologous hematopoietic stem cell transplantation (HSCT).
